PECAM1 and neoplasm: These observations were confirmed by quantification of the CD31-labeled areas through image J software, since Phenacetinum 4CH decreased significantly tumor neovascularization by 1.5-fold (mean percentage at 0.45 for control tumors versus 0.30 for treated tumors, Figure 4D).